About Us
Meet the people behind Variant Bio
Our team's expertise spans genetics, molecular biology, therapeutics, anthropology, and ethics. We are united in the belief that human genomics has the power to transform drug development.
Andrew Farnum
Chief Executive Officer
Bob More
Managing Director, Alta Partners
John Xue
Vice President, SoftBank
Josh Wolfe
Co-Founder and Managing Partner, Lux Capital
Julie Sunderland
Co-Founder and Managing Director, Biomatics Capital
Rob Scott, MD
Former CMO, Abbvie
Stephane Castel, PhD
Co-Founder, Chief Technology Officer & Chief Genomics Officer
Our Investors
